This artice is free to access.
This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness of lutein and zeaxanthin supplementation used for reducing morbidity and mortality in preterm infants, to assess any adverse effects of lutein and zeaxanthin for this purpose, and to consider the effect of the supplementation in terms of route, dose and timing.
Choo, Y. M., Ahmad Kamar, A., Tengku Kamalden, T. A. F., Looi, M. L., Tan, K., & Lai, N. M. (2016, May 4). Lutein and zeaxanthin for reducing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd. https://doi.org/10.1002/14651858.CD012178